Results 211 to 220 of about 2,076,544 (288)
scRNA‐Seq in Gastric Cancer Reveals Macrophage‐Derived C1q as a Diagnostic Marker
Cancer Science, Volume 117, Issue 11, Page 2967-2981, November 2026.Single‐cell sequencing of GC analyzed the tumor microenvironment and discovered the C1QA+ TAMs subpopulation with immunosuppressive function. The role of C1q in the prognosis and diagnosis of GC was demonstrated through plasma and tumor tissue from the GC cohort.Saisai Gong, Yupeng Zhao, Sheng Yang, Tong Liu, Chengyun Li, Yun Zhou, Geyu Liang +6 morewiley +1 more sourceHelicobacter pylori-Related Chronic Gastritis as a Risk Factor for Lower Bone Mineral Density. [PDF]
Calcif Tissue IntInoue I, Yoshimura N, Iidaka T, Horii C, Muraki S, Oka H, Kawaguchi H, Akune T, Maekita T, Mure K, Nakamura K, Tanaka S, Mochida S, Ichinose M. +13 moreeuropepmc +1 more sourceIncidence, severity and potential pathomechanism of immune‐related pruritus in melanoma patients undergoing immune checkpoint inhibitor therapy
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 11, Page 1566-1573, November 2026.Summary Background and objectives
Pruritus is a frequent cutaneous immune‐related adverse event (irAE) associated with immune checkpoint inhibitors (ICI), impacting patients' quality of life. This study investigates the incidence, severity and management of pruritus in melanoma patients treated with ICI.Andrea Roggo, Nikolina Ivanovic, Patrick Turko, Lukas Kraehenbuehl, Mitchell Levesque, Reinhard Dummer, Barbara Meier‐Schiesser +6 morewiley +1 more sourceRetrospective comparison of treatments for equine gastric ulceration syndrome and the influence of inflammatory bowel disease
Equine Veterinary Education, Volume 38, Issue 11, Page e882-e891, November 2026.Summary Background
Equine squamous gastric disease (ESGD) and equine glandular gastric disease (EGGD) can be treated with oral omeprazole, combined with sucralfate or an extended‐release intramuscular omeprazole (ERIO). Objectives
To evaluate these different treatments for ESGD and EGGD and assess the influence of inflammatory bowel disease (IBD) on ...L. C. Kranenburg, C. Ludin, D. A. van Doorn, M. M. Sloet van Oldruitenborgh‐Oosterbaan, P. Witt, R. M. A. C. Houben, R. van den Boom +6 morewiley +1 more sourcePost-COVID-19 Effects on Chronic Gastritis and Gastric Cellular and Molecular Characteristics in Male Mice. [PDF]
Cell Mol Gastroenterol HepatolJeong H, Kim SH, Kim J, Jeon D, Uhm C, Oh H, Cho K, Park IH, Oh J, Kim JJ, Jeong SH, Park JH, Park JW, Yun JW, Seo JY, Shin JS, Goldenring JR, Seong JK, Nam KT. +18 moreeuropepmc +1 more sourceLack of Usefulness of Literature‐Based Helicobacter pylori Resistance Data for Predicting First‐Line Empirical Treatment Effectiveness in the European Registry on H. pylori Management (Hp‐EuReg)
Helicobacter, Volume 31, Issue 6, November/December 2026.ABSTRACT Background
Helicobacter pylori (H. pylori) infection causes gastritis, peptic ulcer disease, and gastric cancer. Without an effective vaccine, eradication therapy remains crucial. However, increasing antibiotic resistance compromises treatment effectiveness.Ismail Kirrout, Olga P. Nyssen, Ángeles Pérez‐Aísa, Bojan Tepes, Irina N. Voynovan, Samuel J. Martínez‐Domínguez, Alfredo J. Lucendo, Ludmila G. Vologzanina, Matteo Pavoni, Sayar R. Abdulkhakov, Maja Denkovski, Javier Tejedor‐Tejada, Tatiana Ilchishina, Luis Bujanda, Aiman S. Sarsenbaeva, Jose M. Huguet, Oleg Zaytsev, Boris D. Starostin, Monica Perona, Antonietta G. Gravina, Manuel Pabón‐Carrasco, Sergey A. Alekseenko, Óscar Núñez, Miguel Areia, Jesús Barrio, Antonio Moreno Loro, Dmitry N. Andreev, Blas José Gómez Rodríguez, María Soledad Marcos, Inmaculada Ortiz‐Polo, Galina N. Tarasova, Igor Bakulin, Mónica Sánchez Alonso, Irene Arteagoitia, Virginia Flores, Manuel Jiménez‐Moreno, Dmitry S. Bordin, Antonio Gasbarrini, Ricardo Marcos‐Pinto, Wojciech Marlicz, Perminder S. Phull, Marino Venerito, Doron Boltin, Lyudmila Boyanova, Pablo Parra, Leticia Moreira, Francis Mégraud, Colm O'Morain, Nuria Montes, Javier P. Gisbert, on behalf of the Hp‐EuReg investigators, Natalia N. Dekhnich, Pilar Mata‐Romero, Natalia Valerievna Bakulina, Alla G. Kononova, Giuseppe Losurdo, Judith Gomez‐Camarero, Alma Keco‐Huerga, Pablo M. Wolfe García, Jurij Bednarik, Eduardo Iyo, Antonia Perelló, Luis Fernández‐Salazar, Noelia Alcaide, Benito Velayos, Pedro Almela, Ramón Pajares Villarroya, Daniel Martin‐Holgado, Miguel Fernández‐Bermejo, Ian L. P. Beales, Alisan Kahraman, Ana Beatriz Pozo Blanco, Montserrat Planella, Mikel Ganuza, Victor A. Kamburov, Marina F. Osipenko, Debora Compare, Georges Kamtoh, Rosa Rosania, Eva Barreiro Alonso, Maria A. Livzan, Teresa Angueira, Consuelo Ramírez, Piotr Szredzki, Natalia Baryshnikova, Natalia Bakanova, Pedro Delgado Guillena, Sheyla Montori Pina, Eduardo Albéniz, Piotr Eder, Inna V. Savilova, Henrique Fernandes‐Mendes, Miguel Suárez Matías, María Badía Martínez, Liya Nikolaevna Belousova, Benito Hermida Pérez, Ana Garre, Natasa Brglez Jurecic, Olga Kolokolnikova, Paola Chaudarcas, Luis Hernández, Regina I. Khlynova, Antonio Cuadrado, Marta Pascual‐Mato, Ekaterina Y. Plotnikova, Mila Kovacheva‐Slavova, Ramiro Carreño Macián, Manon C. W. Spaander, Guillem Soy, Pilar Pazo Mejide, Sergio Gil Rojas, Carlos Maroto‐Martín, Francisco J. Rancel‐Medina, Diego Burgos‐Santamaría, Isabel Pérez‐Martínez, Giulia Fiorini, Teresa Valdés‐Lacasa, Riccardo Vasapolli, Rosa M. Sáiz‐Chumillas, Tamara Matysiak‐Budnik, Anna L. Pakhomova, Jorge Yebra Carmona, Diego Ledro Cano, Senador Moran Sanchez, Jan Bornschein, Pilar Bernal Checa, Antonio M. Caballero‐Mateos, Leticia Gimeno Pitarch, Ángela Martínez Herreros, Nerea Alonso‐Bilbao, Patricia Sanz‐Segura, Jose Xavier Segarra Ortega, Raquel García‐Sánchez, Alexander Link, Jesus M. Gonzalez‐Santiago, Laura Larrey Ruiz, Rodrigo Garcés‐Durán +136 morewiley +1 more source